CA
Cadila Healthcare
CADILAHC.NS·NSEAhmedabad INFounded 195225,000 employees
Large CappharmaPublicOncologyCardiology
Platform: Diversified
Market Cap
$10B
All Drugs
5
Clinical Trials
10
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (CADILAHC.NS)
Loading CADILAHC.NS stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talainavolisib | CAD-866 | Approved | 4 | IL-23 | Atopic Derm | ||
| Gelinaritide | CAD-4225 | Phase 1/2 | 2 | FXIa | Cervical CaEwing Sarcoma | ||
| Datoinavolisib | CAD-2363 | NDA/BLA | 1 | BCMA | SchizophreniaPSP | ||
| CAD-5301 | CAD-5301 | Phase 1/2 | 2 | BCMA | ALLIPF | ||
| Miriratamab | CAD-1253 | NDA/BLA | 1 | DLL3 | LN |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Cadila Healthcare trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (7)